Ellis Investment Partners, LLC Merck & Co., Inc. Transaction History
Ellis Investment Partners, LLC
- $502 Million
- Q3 2024
A detailed history of Ellis Investment Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 25,507 shares of MRK stock, worth $2.5 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
25,507
Previous 23,923
6.62%
Holding current value
$2.5 Million
Previous $2.96 Million
2.2%
% of portfolio
0.58%
Previous 0.64%
Shares
26 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.5 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.43 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.8 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $248B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...